Center for Lymphoid Malignancies
Investigator
Ahmed Sawas, MD
Email
as4386@cumc.columbia.edu
Ahmed Sawas, MD is an Assistant Professor of Medicine and Experimental Therapeutics, in the Center of Lymphoid Malignancies with an appointment to the Division of Hematology/Oncology and the Division of Experimental Therapeutics at the Columbia University College of Physicians and Surgeons and the New York-Presbyterian Hospital in New York City. Dr. Sawas completed his pharmacology degree from Stony Brook University and received his medical degree from the State University of New York - Health Science Center at Brooklyn, College of Medicine in New York. He completed his internship and residency in internal medicine at the St. Vincent’s Catholic Medical Center/ New York Medical College. Dr. Sawas completed his fellowship in hematology and medical oncology at the New York University Medical Center. His research interests are focused on the development of novel therapies for lymphoma, as well as prognostic and predictive biomarkers of early response. Dr. Sawas serves as the principal investigator on many clinical trials and has authored or coauthored many publications and abstracts in peer reviewed journals on the diagnosis and treatment of lymphoma.

Clinical Studies Managed By This Investigator:
Condition Study Title
Lymphoma [ CLOSED ] A new study for patients with Hodgkin's Lymphoma using study drug combination (brentuximab & bendamustine)
Lymphoma [ CLOSED ] A study for subjects with refractory or relapsed lymphoid malignancies using study drug, AGS67E
Lymphoma [ CLOSED ] A study for patients with Diffuse Large B-cell Lymphoma using study drug IMO-8400